Literature DB >> 30513357

Blood pressure variability in surgical and intensive care patients: Is there a potential for closed-loop vasopressor administration?

Joseph Rinehart1, Michael Ma1, Michael David Calderon1, Aurelie Bardaji2, Reda Hafiane2, Philippe Van der Linden3, Alexandre Joosten4.   

Abstract

Blood pressure management in the operating rooms (OR) and intensive care units (ICU) frequently involves manually titrated vasopressor therapy to an optimal range of mean arterial pressure (MAP). Ideally, changes in vasopressor infusion rates have to quickly follow variations in blood pressure measurements. However, such a tightly controlled feedback loop is difficult to achieve. Few studies have examined blood pressure control when vasopressor therapy is administered manually in OR and ICU patients. We extracted MAP data from 3623 patients (2530 from the ORs and 1093 from the ICU) on vasopressors from our electronic medical records. Coefficient of variation (= standard deviation/mean value) *100) was calculated and the values were additionally categorized into different MAP ranges (MAP < 60 mmHg, 60 < MAP < 80 and MAP > 80 mmHg). There was no statistically significant difference between both centres for MAP across all time points (80 ± 12 vs. 80 ± 16, P = 0.996, 95% CI -6 to 6). The coefficients of variation of MAP were 13.7 ± 5.4% and 18.4 ± 9.8% in the OR and in ICU respectively. Patients on vasopressors spent 48.8% treatment time with a MAP between 60 and 80 mmHg (11.2% time with MAP < 60 mmHg, and 40% with MAP > 80 mmHg). These results provide a reasonable baseline from which to establish whether 'reduced variability' may be achieved with a closed-loop vasopressor administration system.
Copyright © 2018. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Closed-loop; Hypertension; Hypotension; Mean arterial pressure; Vasopressors

Mesh:

Substances:

Year:  2018        PMID: 30513357     DOI: 10.1016/j.accpm.2018.11.009

Source DB:  PubMed          Journal:  Anaesth Crit Care Pain Med        ISSN: 2352-5568            Impact factor:   4.132


  6 in total

Review 1.  Automated systems for perioperative goal-directed hemodynamic therapy.

Authors:  Sean Coeckelenbergh; Cedrick Zaouter; Brenton Alexander; Maxime Cannesson; Joseph Rinehart; Jacques Duranteau; Philippe Van der Linden; Alexandre Joosten
Journal:  J Anesth       Date:  2019-09-25       Impact factor: 2.078

2.  Feasibility of closed-loop titration of norepinephrine infusion in patients undergoing moderate- and high-risk surgery.

Authors:  Alexandre Joosten; Brenton Alexander; Jacques Duranteau; Fabio Silvio Taccone; Jacques Creteur; Jean-Louis Vincent; Maxime Cannesson; Joseph Rinehart
Journal:  Br J Anaesth       Date:  2019-06-27       Impact factor: 9.166

3.  Computer-assisted Individualized Hemodynamic Management Reduces Intraoperative Hypotension in Intermediate- and High-risk Surgery: A Randomized Controlled Trial.

Authors:  Alexandre Joosten; Joseph Rinehart; Philippe Van der Linden; Brenton Alexander; Christophe Penna; Jacques De Montblanc; Maxime Cannesson; Jean-Louis Vincent; Eric Vicaut; Jacques Duranteau
Journal:  Anesthesiology       Date:  2021-08-01       Impact factor: 8.986

4.  Perioperative Hypertension Etiologies in Patients Undergoing Noncardiac Surgery in University Health Network Hospitals-Canada from 2015-2020.

Authors:  Sana Mohseni; Sahar Behnam-Roudsari; Mohammad Tarbiat; Pouyan Shaker; Seyedmohammadshahab Shivaie; Mohammad A Shafiee
Journal:  Integr Blood Press Control       Date:  2022-03-19

5.  Automated closed-loop versus manually controlled norepinephrine infusion in patients undergoing intermediate- to high-risk abdominal surgery: a randomised controlled trial.

Authors:  Alexandre Joosten; Dragos Chirnoaga; Philippe Van der Linden; Luc Barvais; Brenton Alexander; Jacques Duranteau; Jean-Louis Vincent; Maxime Cannesson; Joseph Rinehart
Journal:  Br J Anaesth       Date:  2020-10-08       Impact factor: 9.166

6.  Intraoperative Blood Pressure Variability Predicts Postoperative Mortality in Non-Cardiac Surgery-A Prospective Observational Cohort Study.

Authors:  Agnieszka Wiórek; Łukasz J Krzych
Journal:  Int J Environ Res Public Health       Date:  2019-11-09       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.